A nationwide study of acquired C1-inhibitor deficiency in France (original) (raw)
Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation
Roberto Castelli
Autoimmunity Reviews, 2008
View PDFchevron_right
Acquired C1-inhibitor deficiency due to splenic marginal zone lymhoma: Case Report
Daan Dierickx
Acta Clinica Belgica, 2020
View PDFchevron_right
A Unique Case of Angioedema With Anti-C1 Inhibitor Antibodies and Normal C1 Inhibitor Levels
Angelica Petraroli
Journal of Investigational Allergology and Clinical Immunology, 2016
View PDFchevron_right
Acquired angioedema with C1-inhibitor deficiency: similarities and differences with hereditary angioedema
Valentin Nadasan
Alergologia, 2019
View PDFchevron_right
Angioedema as the first presentation of B-cell non-Hodgkin lymphoma – an unusual case with normal C1 esterase inhibitor level: a case report
sonali gunatilake
2014
View PDFchevron_right
Prophylactic treatment with plasma-derived C1 inhibitor in idiopathic non-histaminergic angioedema
Angelica Petraroli
Pediatric Allergy and Immunology, 2016
View PDFchevron_right
Acquired C1-Inhibitor Deficiency: 7 Patients Treated with Rituximab
Christian Drouet
Journal of Clinical Immunology, 2012
View PDFchevron_right
Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedema
Lilian Varga
Molecular Immunology, 2011
View PDFchevron_right
Acquired angioedema in non-Hodgkin’s lymphoma
M. Abuzakouk, Conleth Feighery
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2007
View PDFchevron_right
Retrospective Evaluation of Patients with Angioedema Treated with C1 Inhibitors in an Emergency Department
Funda Akarca
Eurasian Journal of Emergency Medicine
View PDFchevron_right
Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor
Henriette Farkas
Annals of Allergy, Asthma & Immunology, 2016
View PDFchevron_right
An Atypical Case of Idiopathic Nonhistaminergic Angioedema With Anti-C1-INH Antibodies
Angelica Petraroli
Journal of Investigational Allergology and Clinical Immunology, 2022
View PDFchevron_right
Acquired angioedema
andrea zanichelli
Allergy, Asthma & Clinical Immunology, 2010
View PDFchevron_right
Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency
andrea zanichelli
Allergy, 2009
View PDFchevron_right
Treatment of Patients with Hereditary Angioedema with Normal C1 Inhibitor: Evaluation of 295 Patients
Eliana Toledo
Journal of Allergy and Clinical Immunology, 2019
View PDFchevron_right
Review of the Manitoba cohort of patients with hereditary angioedema with normal C1 inhibitor
Lundy McKibbin
Allergy, Asthma & Clinical Immunology, 2019
View PDFchevron_right
Efficacy of icatibant treatment in patients with hereditary angio-oedema type I resistant to treatment with C1 inhibitor concentrate
I. Boccon-Gibod
British Journal of Dermatology, 2011
View PDFchevron_right
C1-inhibitor binding monoclonal immunoglobulins in three patients with acquired angioneurotic edema
Denise Ponard
Journal of Allergy and Clinical Immunology, 1996
View PDFchevron_right
Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Management: A Nationwide Retrospective Study in the Czech Republic Patients
Radana Zachová
International Archives of Allergy and Immunology, 2021
View PDFchevron_right
Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the Italian experience
valeia bafunno
Current opinion in allergy and clinical immunology, 2015
View PDFchevron_right
Angioedema, lymphoproliferative disorder and angiotensin-converting enzyme inhibitors: masking of diagnosis by corticosteroids
Pravin Hissaria
Internal Medicine Journal, 2007
View PDFchevron_right
Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency
Lilian Varga
Clinical Immunology, 2011
View PDFchevron_right
C1-inhibitor/C1-inhibitor antibody complexes in acquired angioedema due to C1-inhibitor deficiency
Henriette Farkas
Orphanet Journal of Rare Diseases, 2023
View PDFchevron_right
C1 Inhibitor Activity and Angioedema Attacks in Patients with Hereditary Angioedema
Joseph Chiao
The Journal of Allergy and Clinical Immunology: In Practice, 2019
View PDFchevron_right
C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema
Henriette Farkas
Molecular Immunology, 2007
View PDFchevron_right
Exposure-Response Analyses of Lanadelumab in Patients with Hereditary Angioedema
Jean-Francois Marier
The Journal of Allergy and Clinical Immunology, 2019
View PDFchevron_right
Angioedema in the emergency department: A presentation of lymphoma
Paul Eliadis
Emergency Medicine Australasia, 2001
View PDFchevron_right
Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients
isabelle boccon-gibod
Annals of Allergy Asthma & Immunology, 2013
View PDFchevron_right
Nine year follow-up of a rare case of angioedema due to acquired C1-inhibitor deficiency with late onset and good response to attenuated androgen
P. Leru
Allergy, Asthma & Clinical Immunology, 2018
View PDFchevron_right
Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency
Lilian Varga
Clinical, Cosmetic and Investigational Dermatology, 2011
View PDFchevron_right